quantitative
Analysis v1
Strong Support

A weekly diabetes shot called exenatide doesn’t seem to lower the risk of serious kidney problems in adults with type 2 diabetes when looking at the raw data. But when researchers adjusted the numbers, it showed a small benefit when including a wider range of kidney issues, like high protein in the urine.

82
Pro
0
Against

Evidence from Studies

Supporting (1)

82

Community contributions welcome

The study looked at a weekly diabetes shot called exenatide and found it didn’t clearly protect kidneys unless they used special number adjustments, which matches what the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.